Tissue Plasminogen Activator Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 REPORT DESCRIPTION Tissue Plasminogen Activator Market – Overview Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration. tPA is also be produced by using recombinant technology techniques known as recombinant tissue plasminogen activator (rtPA). Specific rtPAs are tenecteplase, alteplase, and reteplase. These enzymes are used in clinical treatment of thrombotic stroke or embolic stroke. tPA is a drug that dissolves blood clots. It is a thrombolytic agent which can be administrated into the veins. Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke. Increasing incidences of stroke has boosted the tissue plasminogen activator market size. According to John Hopkins Medicines (JHM) in the U.S., around 795,000 people in the U.S. suffer from stroke per year, as reported in 2014. According to the World Health Organization (WHO), stroke is the second leading cause of death and the third leading cause of disability, worldwide, as reported in 2012. This is one of the major factors driving the tissue plasminogen activator market growth. REPORT DESCRIPTION Tissue Plasminogen Activator Market Taxonomy: By Dosage 2mg 50mg 100mg By Route of administration Intravenous Regional intra-arterial By Application Blood clots Pulmonary embolism Myocardial infarction Stroke Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2469 REPORT DESCRIPTION Tissue Plasminogen Activator Market – Key Players Bayer AG Abcam Calbiochem Merck & Company Roche Sekisui Diagnostics Genentech Sigma-Aldrich Taj Pharmaceuticals Cadila Healthcare Ltd Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/tissue-plasminogen-activator-market-2469 ABOUT COHERENT MARKET INSIGHTS Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CUSTOMIZED RESEARCH CONSULT STUDIES SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies ABOUT US KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702
Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke.
© Copyright 2024 Paperzz